Works matching IS 02698811 AND DT 2024 AND VI 38 AND IP 9
Results: 8
Common protein networks for various drug regimens of major depression are associated with complement and immunity.
- Published in:
- Journal of Psychopharmacology, 2024, v. 38, n. 9, p. 798, doi. 10.1177/02698811241269683
- By:
- Publication type:
- Article
Is lack of goal-conflict-specific rhythmicity a biomarker for treatment resistance in generalised anxiety but not social anxiety or major depression?
- Published in:
- Journal of Psychopharmacology, 2024, v. 38, n. 9, p. 789, doi. 10.1177/02698811241275627
- By:
- Publication type:
- Article
Safety, tolerability and pharmacokinetics of the phosphodiesterase 2 inhibitor BI 474121: An overview of phase I randomized trials in healthy volunteers.
- Published in:
- Journal of Psychopharmacology, 2024, v. 38, n. 9, p. 807, doi. 10.1177/02698811241273814
- By:
- Publication type:
- Article
Insomnia and the effect of zolpidem-extended-release on the sleep items of the Hamilton Rating Scale for Depression in outpatients with depression, insomnia, and suicidal ideation: Relationship to patient age.
- Published in:
- Journal of Psychopharmacology, 2024, v. 38, n. 9, p. 827, doi. 10.1177/02698811241268900
- By:
- Publication type:
- Article
Long-read sequencing of CYP2D6 may improve psychotropic prescribing and treatment outcomes: A systematic review and meta-analysis.
- Published in:
- Journal of Psychopharmacology, 2024, v. 38, n. 9, p. 771, doi. 10.1177/02698811241268899
- By:
- Publication type:
- Article
Re-visiting the association between antidepressant use and the risk of lung cancer.
- Published in:
- Journal of Psychopharmacology, 2024, v. 38, n. 9, p. 832, doi. 10.1177/02698811241268887
- By:
- Publication type:
- Article
Evidence-based guidelines for the interpretation of the 9-item Concise Health Risk Tracking – Self-Report (CHRT-SR<sub>9</sub>) measure of suicidal risk.
- Published in:
- Journal of Psychopharmacology, 2024, v. 38, n. 9, p. 784, doi. 10.1177/02698811241268875
- By:
- Publication type:
- Article
Beneficial adjunctive effects of the 5HT3 receptor antagonist ondansetron on symptoms, function and cognition in early phase schizophrenia in a double-blind, 2 × 2 factorial design, randomised controlled comparison with simvastatin.
- Published in:
- Journal of Psychopharmacology, 2024, v. 38, n. 9, p. 818, doi. 10.1177/02698811241267836
- By:
- Publication type:
- Article